Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin for structural plasticity in healthy older adults
NCT06367738Phase 1Recruiting
- Sponsor
- University of California, Berkeley
- Start
- Nov 2025
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of psilocybin in aging (3 arms), sponsored by University of California, Berkeley. Primary endpoint: MRI measurements of brain structure at 4 weeks. Started Nov 2025; status: recruiting.
02
Drugs
psilocybin
03
Conditions
aging
Beyond the preview
Go deeper on NCT06367738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06367738.